Hikal's Q4 FY 2025-26 Quarterly Results

Result Summary

• Hikal Ltd reported a 5.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 4.9%.
• Its expenses for the quarter were up by 0.5% QoQ and down 2.9% YoY.
• The net profit decreased 344.1% QoQ and decreased 71.3% YoY.
• The earnings per share (EPS) of Hikal Ltd stood at 1.17 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Hikal Ltd is a diversified company operating in the chemical and pharmaceutical industries. The company provides solutions across the life sciences spectrum, including the manufacture of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. Hikal serves a range of clients, including pharmaceutical, biotechnology, agrochemical companies, and animal health organizations. The company is known for its strong research and development capabilities and a focus on delivering high-quality, innovative solutions to its customers. As of the latest available information, there are no specific major developments mentioned for Hikal Ltd.

Revenue

For the fourth quarter of the fiscal year 2026 (Q4FY26), Hikal Ltd reported a total income of ₹526.00 crores. This represents a quarter-over-quarter (QoQ) increase of 5.8% compared to ₹497.10 crores in Q3FY26. However, there is a year-over-year (YoY) decline of 4.9% from ₹552.90 crores reported in Q4FY25. The fluctuations in quarterly revenue are indicative of changes in sales performance or market conditions affecting the company's operations within this period.

Profitability

Hikal Ltd's profitability metrics for Q4FY26 show a profit before tax (PBT) of ₹8.30 crores. This marks a significant improvement from a loss of ₹9.20 crores in the previous quarter (Q3FY26), highlighting a 190.2% QoQ change. In contrast, there is an 87.8% YoY decrease from a PBT of ₹68.30 crores in Q4FY25. The tax expense for the quarter was reported at -₹6.10 crores, showing an 84.8% increase QoQ and a 133.7% decrease YoY. Profit after tax (PAT) stands at ₹14.40 crores for Q4FY26, compared to a loss of ₹5.90 crores in Q3FY26, demonstrating a 344.1% QoQ improvement, but a 71.3% decline YoY from ₹50.20 crores in Q4FY25. The earnings per share (EPS) for Q4FY26 is ₹1.17, compared to -₹0.48 in Q3FY26 and ₹4.07 in Q4FY25.

Operating Metrics

In Q4FY26, Hikal Ltd's total expenses amounted to ₹470.60 crores, reflecting a marginal increase of 0.5% from ₹468.30 crores in Q3FY26 and a 2.9% decrease compared to ₹484.60 crores in Q4FY25. The company's financial performance indicates variations in operational spending and cost management over the quarters. Due to the lack of detailed balance sheet data, specific financial ratios such as the P/E ratio, debt-to-equity ratio, or current ratio cannot be calculated at this time.